Basilic vein transposition versus biosynthetic prosthesis as vascular access for hemodialysis Massimo Morosetti, MD, Silvia Cipriani, MD, Sara Dominijanni, MD, Giovanni Pisani, MD, Daniele Frattarelli, MD, Fabrizio Bruno, MD Journal of Vascular Surgery Volume 54, Issue 6, Pages 1713-1719 (December 2011) DOI: 10.1016/j.jvs.2011.06.030 Copyright © 2011 Society for Vascular Surgery Terms and Conditions
Fig 1 Primary patency is shown for arteriovenous graft (AVG) and brachial-basilic arteriovenous fistula (BBAVF) at 24 months. The standard error was >10% for BBAVF at 375 days. Journal of Vascular Surgery 2011 54, 1713-1719DOI: (10.1016/j.jvs.2011.06.030) Copyright © 2011 Society for Vascular Surgery Terms and Conditions
Fig 2 Secondary patency is shown for arteriovenous graft (AVG) and brachial-basilic arteriovenous fistula (BBAVF) at 24 months. The standard error was <10% in each group. Journal of Vascular Surgery 2011 54, 1713-1719DOI: (10.1016/j.jvs.2011.06.030) Copyright © 2011 Society for Vascular Surgery Terms and Conditions